- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07280182
Effect of the Quadratus Lumborum Block Versus the Lumbar Plexus for Spiral Thighplasty Surgery (QLB&LPB)
March 15, 2026 updated by: Amal Gouda Elsayed Safan, Menoufia University
Comparing the Early Postoperative Analgesic Effect of the Transmuscular Quadratus Lumborum Block Versus the Lumbar Plexus Block for Patients Undergoing Spiral Thighplasty Surgery
Whether trans muscular QLB provides postoperative analgesia compared with LPB after thigh lift surgery
Study Overview
Status
Completed
Conditions
Detailed Description
Adequate analgesia after spiral thigh reduction (thigh lift) is essential for early mobilization and patient satisfaction.
Quadratus lumborum block (QLB) has shown analgesic efficacy comparable to lumbar plexus block (LPB) for hip area surgery with potential advantages in motor-sparing and safety
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shibin El Kom
-
Cairo, Shibin El Kom, Egypt, 32511
- Faculty of medicine,Menofia university hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ASA ( American Society of Anaesthesia) I-II
- elective bilateral spiral thigh lift under general anesthesia
- consent to regional block and trial participation
Exclusion Criteria:
- Coagulopathy or therapeutic anticoagulation not meeting ASRA safety windows
- infection at injection sites
- allergy to local anesthetics
- preexisting significant neuropathy
- BMI > 35 kg/m² if impeding ultrasound visualization; renal/hepatic failure; pregnancy; inability to use NRS; chronic opioid use >60 mg oral morphine equivalents/day; contraindication to study analgesics.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Group QLB
Ultrasound-Guided Trans-muscular QLB
|
With the patient lateral decubitus position, a low-frequency curvilinear probe in the 'Shamrock' view at L2-L4.
In-plane posterior-to-anterior needle advancement through the Quadratus lumborum to the interfascial plane anterior to QL and posterior to Psoas major.
Inject 30 mL Bupivacaine 0.25% after negative aspiration and hydrodissection to confirm proper spread .
Then the patient will be turned to the other side, and the block will be done with the same technique
|
|
Other: Group LPB
Ultrasound-Guided Posterior Lumbar Plexus (Psoas Compartment) Block
|
Lateral decubitus, Shamrock view to identify the Psoas compartment; in-plane needle advancement to the Psoas compartment adjacent to the transverse process.
Inject 30 mL of Bupivacaine 0.25% in 5 mL increments, aspirating frequently.
This will be done in the same position for both sides
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual analogue scale score
Time Frame: 24 hours
|
Visual analogue scale score at 1st,6th,12th and 24 h (where 0 is interpreted as no pain, 1-4 mild pain, 5-6 moderate pain, 7-10 severe pain)
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time for first analgesic request
Time Frame: 24 hours
|
first analgesic request
|
24 hours
|
|
Opioid consumption
Time Frame: 24 hours
|
cumulative opioid consumption
|
24 hours
|
|
Time to walk >30 (meter)
Time Frame: 24 hours
|
walk >30 (meter)
|
24 hours
|
|
Performance Time
Time Frame: minutes
|
block performance time
|
minutes
|
|
The number of patients who develop block-related complications
Time Frame: 24 hours
|
nausea and vomiting , hypotension
|
24 hours
|
|
the patients Satisfaction questionnaire
Time Frame: 24 hours
|
pateints are either : Dissatisfied Neither satisfied nor dissatisfied Satisfied Very satisfied
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: AMAL G SAFAN, MD, Menoufia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 13, 2025
Primary Completion (Actual)
February 28, 2026
Study Completion (Actual)
March 14, 2026
Study Registration Dates
First Submitted
November 28, 2025
First Submitted That Met QC Criteria
December 11, 2025
First Posted (Actual)
December 12, 2025
Study Record Updates
Last Update Posted (Actual)
March 17, 2026
Last Update Submitted That Met QC Criteria
March 15, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 11/2025ANET2
- Menoufia University (Registry Identifier: Faculty of medicine)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
University Hospital, CaenNot yet recruitingPostoperative Care | Postoperative Analgesia | Analgesia Assessment | PosthectomyFrance
-
Brigham and Women's HospitalEnrolling by invitationEpidural Analgesia | Learning Curve | Epidural Analgesia for Labour and DeliveryUnited States
-
Dr. John A. Thiel Medical Professional CorporationNot yet recruiting
-
Tanta UniversityRecruiting
-
SSM Health Bone and Joint Hospital at St AnthonyRecruitingAnalgesiaUnited States
-
Makassed General HospitalRecruiting
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Abd-Elazeem Abd-Elhameed ElbakryActive, not recruiting
Clinical Trials on Ultrasound-Guided Trans-muscular QLB
-
Ain Shams UniversityActive, not recruiting
-
Assiut UniversityUnknownPostoperative Pain ManagementEgypt
-
National Cancer Institute, EgyptNational Cancer Institute (NCI)Not yet recruitingPostoperative Analgesia
-
University of MilanCompleted
-
Seoul National University HospitalActive, not recruitingRespiratory InsufficiencyKorea, Republic of
-
Assiut UniversityNot yet recruitingOvarian Diseases
-
Centre Hospitalier Régional d'OrléansTerminated
-
Yale UniversityPeking University First Hospital; The Second Hospital of Hebei Medical University and other collaboratorsCompletedPostoperative Nausea and Vomiting | Hysterectomy | Tissue Oxygenation | Blood Pressure Management | Cardiac Output ManagementChina
-
Cairo UniversityNot yet recruitingUltrasound Therapy; Complications
-
Maxima Medical CenterRecruitingPregnancy Related | Female | Human | Placenta Diseases, DiagnosisNetherlands